Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to ...

Gilead Sciences (GILD) is one of the stocks most ... While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to ...

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target hoisted by equities researchers at Morgan Stanley from $123.00 to $130.00 in a research note issued to investors on ...

Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...

February 24, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s Marketing ...

Gilead Sciences, Inc. (NASDAQ:GILD), a prominent player in ... According to InvestingPro analysis, the company appears overvalued at current levels, though it maintains a "GREAT" financial health ...

Gilead Sciences, Inc. (NASDAQ:GILD), a prominent player in the biotechnology ... According to InvestingPro analysis, the company appears overvalued at current levels, though it maintains a "GREAT" ...

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet ...